( 10.1126/scitranslmed.3007218) [DOI] [PubMed] [Google Scholar] Finan B, Yang B, Ottaway N, Smiley DL, Ma T, Clemmensen C, Chabenne J, Zhang L, Habegger KM, Fischer K, et al
Check manufacturer assistance programs
If you go through a telehealth platform, verify whether you are receiving FDA-approved brand-name medication or a compounded version, and understand the regulatory risks
Ozempic carries a risk of pancreatitis (inflammation of the pancreas), kidney problems, and gallbladder disease, though these are uncommon
The medication is administered via subcutaneous injection, typically on a weekly basis, though dosing frequency and amounts may be individualized based on patient response and tolerability
Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion